Eupraxia Pharmaceuticals (EPRX.US) Stock Community - Hot Topic Discussions

Event Tracking

Nov14

Cantor Fitzgerald Analyst Reiterates Buy Rating on Eupraxia Pharmaceuticals

14:07

Nov5

Eupraxia Pharmaceuticals released FY2025 9 Months Earnings on November 4, 2025 (EST) with actual revenue of USD 0 and EPS of USD -0.6579

04:00

Eupraxia Pharmaceuticals released FY2025 Q3 earnings on November 4 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.1898 (forecast USD -0.192)

04:00

Nov4

Eupraxia Pharmaceuticals Releases Q3 Management's Discussion and Analysis Report

23:00

Oct1

Lowe and Cantor Fitzgerald Maintain Buy Rating on Eupraxia Pharmaceuticals

13:28

Aug13

Eupraxia Pharmaceuticals released FY2025 Q2 earnings on August 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.2612 (forecast USD -0.2016)

03:00